share_log

Shareholders in Omnicell (NASDAQ:OMCL) Have Lost 70%, as Stock Drops 3.2% This Past Week

Shareholders in Omnicell (NASDAQ:OMCL) Have Lost 70%, as Stock Drops 3.2% This Past Week

Omnicell(納斯達克股票代碼:OMCL)的股東下跌了70%,上週股價下跌了3.2%
Simply Wall St ·  2023/12/06 06:16

Omnicell, Inc. (NASDAQ:OMCL) shareholders should be happy to see the share price up 10% in the last month. But that doesn't change the fact that the returns over the last three years have been disappointing. Indeed, the share price is down a tragic 70% in the last three years. So it's good to see it climbing back up. After all, could be that the fall was overdone.

Omnicell, Inc.(納斯達克股票代碼:OMCL)的股東應該很高興看到上個月股價上漲了10%。但這並不能改變過去三年的回報令人失望的事實。事實上,股價在過去三年中悲慘地下跌了70%。因此,很高興看到它回升。畢竟,可能是秋天已經過頭了。

Since Omnicell has shed US$51m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.

由於Omnicell在過去7天內已將其價值減少了5100萬美元,因此讓我們看看長期下跌是否是由該企業的經濟推動的。

Check out our latest analysis for Omnicell

查看我們對 Omnicell 的最新分析

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

不可否認的是,市場有時是有效的,但價格並不總是能反映潛在的業務表現。研究市場情緒如何隨着時間的推移而發生變化的一種方法是研究公司的股價與每股收益(EPS)之間的相互作用。

Over the three years that the share price declined, Omnicell's earnings per share (EPS) dropped significantly, falling to a loss. Due to the loss, it's not easy to use EPS as a reliable guide to the business. However, we can say we'd expect to see a falling share price in this scenario.

在股價下跌的三年中,Omnicell的每股收益(EPS)大幅下降,跌至虧損。由於虧損,使用EPS作爲可靠的業務指南並不容易。但是,我們可以說,在這種情況下,我們預計股價將下跌。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖描繪了 EPS 隨時間推移而發生的變化(點擊圖片顯示確切值)。

earnings-per-share-growth
NasdaqGS:OMCL Earnings Per Share Growth December 6th 2023
納斯達克GS:OMCL 每股收益增長 2023 年 12 月 6 日

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

我們認爲,內部人士在去年進行了大量收購,這是積極的。即便如此,未來的收益對於當前股東能否賺錢要重要得多。在買入或賣出股票之前,我們始終建議仔細研究歷史增長趨勢,可在此處查閱。

A Different Perspective

不同的視角

Investors in Omnicell had a tough year, with a total loss of 29%, against a market gain of about 17%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 9% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. If you want to research this stock further, the data on insider buying is an obvious place to start. You can click here to see who has been buying shares - and the price they paid.

Omnicell的投資者經歷了艱難的一年,總虧損了29%,而市場漲幅約爲17%。即使是優質股票的股價有時也會下跌,但我們希望在過於感興趣之前看到企業基本指標的改善。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨9%的總虧損。我們意識到羅斯柴爾德男爵曾說過,投資者應該 “在街頭流血時買入”,但我們警告說,投資者應首先確保他們購買的是高質量的企業。如果你想進一步研究這隻股票,內幕買入的數據顯然是一個起點。你可以點擊這裏查看誰在購買股票以及他們支付的價格。

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

還有很多其他公司有內部人士購買股票。你可能不想錯過這份業內人士正在收購的成長型公司的免費名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論